Loading...

Regulating and controling "designer drugs" such as K2?

321 views

Loading...

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 8, 2012

At a panel discussion titled: "Policies and technologies needed to rein in 'designer drugs'", hosted by RTI International, SSDP Associate Director, Stacia Cosner, asks the panelists about the potential benefits of a regulation and control approach to the issue as opposed to a criminalization approach. "Designer drugs" are referring to substances such as synthetic cannabinoids like K2, or "spice", bath salts, etc.

Loading...

to add this to Watch Later

Add to

Loading playlists...